PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The ability to directly measure whole-body fluorescence can enable tracking of labeled cells, metastatic spread, and drug bio-distribution. We describe the development of a new hyperspectral imaging whole body cryomacrotome designed to acquire 3-D fluorescence volumes in large specimens (whole animals) at high resolution. The use of hyperspectral acquisition provides full spectra at every voxel, enabling spectral decoupling of multiple fluorohpores and autofluorescence. We present examples of tissue spectra and spectral fitting in a rodent glioma xenograft.
Boyu Meng,Brook K. Byrd,Dennis J. Wirth,Rendall R. Strawbridge, andScott C. Davis
"Developing a novel hyperspectral imaging cryomacrotome for whole body fluorescence imaging", Proc. SPIE 11219, Visualizing and Quantifying Drug Distribution in Tissue IV, 112190M (21 February 2020); https://doi.org/10.1117/12.2544497
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Boyu Meng, Brook K. Byrd, Dennis J. Wirth, Rendall R. Strawbridge, Scott C. Davis, "Developing a novel hyperspectral imaging cryomacrotome for whole body fluorescence imaging," Proc. SPIE 11219, Visualizing and Quantifying Drug Distribution in Tissue IV, 112190M (21 February 2020); https://doi.org/10.1117/12.2544497